CJCADR’s research pipeline connects foundational discovery with practical outcomes for people living with dementia. Discovery research underpins this work, with scientists investigating how dementia begins, progresses and disrupts brain function at molecular, cellular and systems levels.
Building on these insights, CJCADR advances translational research focused on new therapeutic targets, earlier and more accurate diagnosis, and strategies to slow or prevent disease progression. Promising discoveries are refined and positioned for clinical application through defined translational stages.
